A previous study in DN patients showed that LDP could improve symptoms and signs of DN and inhibit erythrocyte aldose reductase (EAR) activity and lower UAER levels, β2-microglobulin in blood and urine without affecting blood glucose, lipids, and mean arterial pressure [32]. The gene discussed is AKR1B1; the disease is liver dysplastic nodule.